Shields J A, Eagle R C, Shields C L, Potter P D
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Ophthalmology. 1996 Dec;103(12):1998-2006. doi: 10.1016/s0161-6420(96)30394-1.
Most reports on intraocular medulloepithelioma have been single case descriptions. The authors reviewed ten patients with intraocular medulloepithelioma, discuss some little known clinical features of this entity, and make diagnostic and therapeutic recommendations.
The records of the authors' patients with histopathologically confirmed medulloepithelioma were reviewed, and the clinical features, diagnostic problems, management, histopathology, and prognosis were assessed.
Of the ten patients, nine were children, ranging in age from 2 months to 10 years, and one patient was 58 years of age at the time of clinical presentation. In seven patients, there was a delay in diagnosis, ranging from 3 to 28 months, and four patients underwent surgery for cataract, glaucoma, or other secondary conditions while the tumor was unsuspected. All patients had a nonpigmented ciliary body mass and a notched or subluxated lens, and six had neovascular glaucoma and evident cysts in the mass. The authors' initial management was enucleation in four patients and local resection in six. Of the six patients managed by local resection, five eventually required enucleation, four because of local tumor recurrence and one because of ocular inflammation and discomfort. Pathologically, nine tumors were classified as malignant (5 teratoid, 4 nonteratoid) and one as benign. In one patient (the adult), metastasis to the parotid gland developed.
Intraocular medulloepithelioma generally occurs in the first decade of life as a nonpigmented ciliary body mass. It has a tendency to cause secondary neovascular glaucoma, a characteristic lens notch and subluxation, and a neoplastic cyclitic membrane. Enucleation is the best treatment for advanced cases. For smaller circumscribed lesions, local resection may be attempted, but such treatment is followed frequently by local recurrence. Although most medulloepitheliomas are cytologically malignant, distant metastasis is uncommon.
大多数关于眼内髓上皮瘤的报告都是单个病例描述。作者回顾了10例眼内髓上皮瘤患者,讨论了该疾病一些鲜为人知的临床特征,并提出了诊断和治疗建议。
回顾了作者经组织病理学确诊为髓上皮瘤的患者记录,并评估了临床特征、诊断问题、治疗、组织病理学和预后。
10例患者中,9例为儿童,年龄从2个月至10岁不等,1例患者临床表现时年龄为58岁。7例患者诊断延迟,时间为3至28个月,4例患者在未怀疑有肿瘤的情况下因白内障、青光眼或其他继发疾病接受了手术。所有患者均有非色素性睫状体肿物和晶状体切迹或半脱位,6例有新生血管性青光眼且肿物内有明显囊肿。作者最初的治疗方法是4例行眼球摘除术,6例行局部切除术。在6例行局部切除术的患者中,5例最终需要行眼球摘除术,4例是因为局部肿瘤复发,1例是因为眼部炎症和不适。病理上,9例肿瘤被分类为恶性(5例畸胎样,4例非畸胎样),1例为良性。1例患者(成人)发生了腮腺转移。
眼内髓上皮瘤通常发生在生命的第一个十年,表现为非色素性睫状体肿物。它倾向于引起继发性新生血管性青光眼、特征性的晶状体切迹和半脱位以及肿瘤性睫状膜。对于晚期病例,眼球摘除术是最佳治疗方法。对于较小的局限性病变,可尝试局部切除术,但这种治疗后局部复发很常见。虽然大多数髓上皮瘤在细胞学上是恶性的,但远处转移并不常见。